Skip to content
Explore expert reviews, tips, and guides for online slots a…

Patients Stopping Anti-Obesity Jabs Gain Back Weight at a Quadrupled Rate Than Those on Conventional Diets

Illustration of pharmaceutical injection and scale
Weight management involves long-term strategies.

Fresh analysis reveals that patients who come off new GLP-1 drugs like Wegovy and Mounjaro can put back on reduced body mass far faster than those who stop traditional lifestyle plans.

Findings released in a major health publication shows that while overweight individuals can lose substantial amounts of their body weight while on the medication, the mass is regained at an estimated rate of 0.8 kg per month after stopping.

"People using these treatments should be aware of the danger of fast weight regain when the therapy ends," warns expert Dr. Susan Jebb.

Such speed of regain suggests a return to starting weight within about one and a half years.

Weighing Approaches

The analysis, which looked at 37 of studies involving thousands of patients, contrasted the results of these new drugs with other pills.

The team point out that individuals who lose weight through lifestyle changes alone usually experience a more gradual weight regain—approximately 100 grams monthly—once they finish.

Understanding the Rapid Rebound

Nutrition scientists suggest the mechanism of the jabs is key to understanding the accelerated rebound.

GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which moderates hunger.

"Long-term administration of GLP-1 levels several times higher than normal might result in the body to produce less of its endogenous GLP-1, and could diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition expert.

"Withdrawal of this GLP-1 'fix' means hunger is unsuppressed, making overeating much more probable."

A Chronic Condition?

The NHS advise the jabs for people with obesity-related medical conditions, alongside recommended diet and exercise modifications.

Many experts argue that, due to the high risk of relapse, the treatment should be considered long-term.

This perspective is reinforced by pharmaceutical companies, who state that the findings "emphasize the chronic character of obesity," akin to managing diseases like high blood pressure.

Patient Accounts

Users who have discontinued the jabs explain a powerful resurgence of hunger.

"It felt as if a trigger that goes on and you become extremely hungry," said one woman.

This difficulty is exacerbated if patients have not adopted permanent dietary or behavioural changes during treatment.

Widespread Interest

Figures suggest that a significant number of adults in the UK have used weight-loss jabs in the past year, with demand remaining high.

  • Adoption is higher among females than males.
  • The 40s and 50s age group shows the highest usage rates.
  • A large proportion obtain the medications through private healthcare rather than public health services.

In conclusion, researchers emphasize that while the jabs are powerful agents for shedding pounds, they are not a permanent solution and lasting health benefits relies on integrated behavioural changes.

LD
The writer

Lauren Downs

A seasoned gaming journalist with over a decade of experience covering online casinos and slot mechanics across Europe.

GameCore Slots UK

Type to search articles.